1 Min Read
Sept 5 (Reuters) - Eiger Biopharmaceuticals Inc:
* Eiger announces FDA orphan drug designation granted for pegylated interferon lambda in hepatitis delta virus infection Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.